Full Name
Dr. John Heymach
Job Title
Professor & Chairman, Department of Thoracic/Head & Neck Medical Oncology
Company
The University of Texas MD Anderson Cancer Center
Speaker Bio
Dr. John V. Heymach is the Chairman of Thoracic/Head and Neck Medical Oncology, the Chief of Thoracic Medical Oncology, and an Associate Professor in the Departments of Thoracic Head and Neck Medical Oncology and Cancer Biology at The University of Texas MD Anderson Cancer Center.
Dr. Heymach joined the MD Anderson faculty in 2005 as an assistant professor, with a joint appointment in Thoracic/Head and Neck Medical Oncology and Cancer Biology. He was promoted to associate professor in 2009. He received his undergraduate degree from Harvard University and both his MD and PhD from Stanford University Medical School in California. He then completed his internship and residency at Brigham and Women’s Hospital and his fellowship in Medical Oncology at Dana-Farber Cancer Institute. During his fellowship, Dr. Heymach worked in the prestigious laboratory of Dr. Judah Folkman with clinical mentorship under Dr. Bruce Johnson.
Dr. Heymach's research focuses on investigating mechanisms of therapeutic resistance, understanding the regulation of angiogenesis in lung cancer, and developing biomarkers for selecting patients most likely to benefit from targeted agents. Dr. Heymach has led a number of Phase I/II clinical trials in NSCLC and currently serves as the principal investigator on the BATTLE-frontline trial using novel combinations of targeted agents as frontline therapy for NSCLC patients. His work has been extensively published in prominent peer-reviewed journals.
Dr. Heymach currently serves as a project co-leader on the Lung Cancer and Head and Neck SPOREs, and is the PI on an NCI R01 award, a LUNGevity Foundation grant, and an AACR Stand Up to Cancer grant. He is the recent recipient of a V Foundation Translational Research Award, on which he serves as PI. He also serves as a co-leader of the MD Anderson Lung Cancer Moon Shot Project. He is a past recipient of the Damon Runyon Clinical Investigator Award, an ASCO Career Development Award, the Wilson Stone Award for Basic Science Research, the Emil J. Frei Award for Translational Research, and the MD Anderson Physician Scientist award. He was elected to the American Society for Clinical Investigation in 2013.
Dr. Heymach is dedicated to education and mentorship, as recognized when he was awarded Mentor of the Year in 2008. He is extremely supportive of his trainees and has supervised numerous graduate students, postdoctoral and medical oncology fellows, and junior faculty.
Dr. Heymach joined the MD Anderson faculty in 2005 as an assistant professor, with a joint appointment in Thoracic/Head and Neck Medical Oncology and Cancer Biology. He was promoted to associate professor in 2009. He received his undergraduate degree from Harvard University and both his MD and PhD from Stanford University Medical School in California. He then completed his internship and residency at Brigham and Women’s Hospital and his fellowship in Medical Oncology at Dana-Farber Cancer Institute. During his fellowship, Dr. Heymach worked in the prestigious laboratory of Dr. Judah Folkman with clinical mentorship under Dr. Bruce Johnson.
Dr. Heymach's research focuses on investigating mechanisms of therapeutic resistance, understanding the regulation of angiogenesis in lung cancer, and developing biomarkers for selecting patients most likely to benefit from targeted agents. Dr. Heymach has led a number of Phase I/II clinical trials in NSCLC and currently serves as the principal investigator on the BATTLE-frontline trial using novel combinations of targeted agents as frontline therapy for NSCLC patients. His work has been extensively published in prominent peer-reviewed journals.
Dr. Heymach currently serves as a project co-leader on the Lung Cancer and Head and Neck SPOREs, and is the PI on an NCI R01 award, a LUNGevity Foundation grant, and an AACR Stand Up to Cancer grant. He is the recent recipient of a V Foundation Translational Research Award, on which he serves as PI. He also serves as a co-leader of the MD Anderson Lung Cancer Moon Shot Project. He is a past recipient of the Damon Runyon Clinical Investigator Award, an ASCO Career Development Award, the Wilson Stone Award for Basic Science Research, the Emil J. Frei Award for Translational Research, and the MD Anderson Physician Scientist award. He was elected to the American Society for Clinical Investigation in 2013.
Dr. Heymach is dedicated to education and mentorship, as recognized when he was awarded Mentor of the Year in 2008. He is extremely supportive of his trainees and has supervised numerous graduate students, postdoctoral and medical oncology fellows, and junior faculty.
